Skip to main content
. 2015 Sep 1;11:1345–1353. doi: 10.2147/TCRM.S89737

Table 4.

Reasons for patient discontinuing selected clinical trials of metformin and oral contraceptive pills in treatment of polycystic ovary syndrome

Trial Number of patient withdrawals, n Reasons
Glintborg et al10 M: 11 M: pregnant (n=1), wanted OCP (n=2), depression (n=1), nausea (n=1), regrets (n=4), lost to follow-up (n=2)
M + OCP: 7 M + OCP: nausea (n=3), regrets (n=2), lost to follow-up (n=2)
OCP: 7 OCP: wants pregnancy (n=2), side effects (n=3), lost to follow-up (n=2)
Essah et al19 M + OCP: 2 M + OCP: lost to follow-up (n=1), moved away (n=1)
OCP + Pl: 2 OCP + Pl: lost to follow-up (n=1), heavy menstrual bleeding (n=1)
Panidis et al20 Group A: 0
Group B: 0
Group C: 0
Bilgir et al21 M + OCP: 0
OCP: 0
Mitkov et al14 M: 0
M + OCP: 0
Morin-Papunen et al12 M: 2 M: moved away (n=1), personal reasons (n=1)
OCP: 1 OCP: headache and high blood pressure (n=1)
Elter et al22 M + OCP: 0
OCP: 0
Morin-Papunen et al23 M: 5 M: moved away (n=1), personal reasons (n=1), manifest diabetes mellitus (n=2), continuous nausea and diarrhea (n=1)
OCP: 2 OCP: manifested diabetes mellitus (n=1), headache and high blood pressure (n=1)

Abbreviations: M, metformin; OCP, oral contraceptive pill; Pl, placebo.